Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank38
Studio
Year-over-Year Change

Free cash flow yield

Latest
-22.45%
↑ 65% vs avg
Percentile
P38
Within normal range
Streak
2 yr
Consecutive growthElevated
Average
-63.78%
Historical baseline
PeriodValueYoY Change
2025-22.45%+67.6%
2024-69.19%+80.6%
2023-357.57%-335.6%
2022-82.09%-424.4%
2021-15.65%-22.7%
2020-12.76%+55.3%
2019-28.56%-101.5%
2018-14.17%+28.9%
2017-19.93%-29.0%
2016-15.45%-